INMD
InMode Ltd.
Price Chart
Latest Quote
$14.89
+0.11 (+0.71%)
Current Price
| Previous Close | $14.79 |
| Open | $14.75 |
| Day High | $14.96 |
| Day Low | $14.63 |
| Volume | 560,291 |
Stock Information
| Shares Outstanding | 57.48M |
| Total Debt | $4.83M |
| Cash Equivalents | $537.16M |
| Revenue | $374.64M |
| Net Income | $87.19M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $856.18M |
| P/E Ratio | 11.03 |
| EPS (TTM) | $1.35 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $405.37M |
| Sales | $374.64M |
| Income | $87.19M |
| Book/sh | $10.78 |
| Cash/sh | $9.35 |
| Employees | 660 |
Financial Ratios
| Quick Ratio | 7.47 |
| Current Ratio | 8.80 |
| Debt/Eq | 0.73 |
| EPS Growth TTM | -36.50% |
Returns & Margins
| ROA | 6.86% |
| ROE | 13.62% |
| Gross Margin | 77.84% |
| Operating Margin | 12.26% |
| Profit Margin | 23.27% |
Ownership
| Insider Ownership | 13.14% |
| Institutional Ownership | 59.76% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 10.24 |
| PEG | 0.83 |
| P/S | 2.29 |
| P/B | 1.38 |
Analyst Data
| Recommendation | none |
| Target Price | $14.33 |
Technical Indicators
| SMA20 | $13.66 |
| SMA50 | $13.94 |
| SMA200 | $14.36 |
| RSI | 74.76 |
| ATR | 0.3254 |
| Shares Float | 53.89M |
| Short Float | 5.05% |
| Short Ratio | 2.78 |
| Volatility | 1.93 |
| Rel Volume | 0.75 |
Performance History
| Week | +11.49% |
| Month | +7.86% |
| Quarter | +8.33% |
| 6 Months | +3.22% |
| YTD | +0.64% |
| Year | +8.25% |
| 3 Years | -60.29% |
| 5 Years | -68.54% |
| 10 Years | +119.53% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-25 | $14.90 | 560,291 |
| 2026-06-24 | $14.79 | 3,497,400 |
| 2026-06-23 | $13.35 | 521,600 |
| 2026-06-22 | $13.21 | 721,800 |
| 2026-06-18 | $13.40 | 568,600 |
| 2026-06-17 | $13.36 | 618,700 |
| 2026-06-16 | $13.49 | 652,200 |
| 2026-06-15 | $13.57 | 673,000 |
| 2026-06-12 | $13.45 | 448,400 |
| 2026-06-11 | $13.49 | 515,100 |
| 2026-06-10 | $13.47 | 487,900 |
| 2026-06-09 | $13.56 | 526,300 |
| 2026-06-08 | $13.50 | 425,900 |
| 2026-06-05 | $13.54 | 497,200 |
| 2026-06-04 | $13.62 | 406,200 |
| 2026-06-03 | $13.49 | 732,000 |
| 2026-06-02 | $13.50 | 573,800 |
| 2026-06-01 | $13.59 | 791,900 |
| 2026-05-29 | $13.93 | 979,500 |
| 2026-05-28 | $14.05 | 721,100 |
| 2026-05-27 | $13.81 | 1,024,500 |
| 2026-05-26 | $13.81 | 1,193,000 |
About InMode Ltd.
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. The company also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions. In addition, it offers hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company sells and markets its products in the United States, Canada, the United Kingdom, Ireland, Spain, Portugal, France, Belgium, Luxemburg, Italy, Germany, Austria, Japan, Australia, and India through distributors. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. The company was incorporated in 2008 and is headquartered in Yokne'am, Israel.
đ° Latest News
Medical Aesthetics Play Flies On Unsolicited Takeover Bid; Why It Makes Sense
Investor's Business Daily âĸ 2026-06-24T20:05:21Z
Sector Update: Healthcare Stocks Advance Late Afternoon
MT Newswires âĸ 2026-06-24T19:32:09ZINMD Stock Heads For Best Day In Nearly Six Months â How Does The Latest Takeover Proposal Compare To Steel Partnersâ Offer?
Stocktwits âĸ 2026-06-24T14:41:51Z
Inmode Ltd (INMD) Reports Solid Numbers in a Soft Market
Insider Monkey âĸ 2026-05-27T21:19:32Z
Doma Perpetual Buys Another $5.6 Million of Nomad Foods With the Stock Down 20% in 2026
Motley Fool âĸ 2026-05-21T15:37:08Z
Undervalued Small Caps With Insider Buying To Watch In May 2026
Simply Wall St. âĸ 2026-05-14T11:39:51Z
InMode Ltd. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-06T20:52:04Z
InMode (INMD) Q1 2026 Earnings Call Transcript
Motley Fool âĸ 2026-05-06T20:03:45Z
InMode Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-06T18:34:04Z
Assessing InMode (INMD) Valuation After Reaffirmed 2026 Revenue Guidance
Simply Wall St. âĸ 2026-04-27T07:04:23Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $79,525,000 | $77,752,000 | $80,708,000 | $73,485,000 |
| Cost Of Revenue | $79,525,000 | $77,752,000 | $80,708,000 | $73,485,000 |
| Total Revenue | $370,495,000 | $394,818,000 | $492,048,000 | $454,271,000 |
| Operating Revenue | $370,495,000 | $394,818,000 | $492,048,000 | $454,271,000 |
| Expenses | ||||
| Total Expenses | $285,108,000 | $282,287,000 | $296,388,000 | $256,417,000 |
| Net Non Operating Interest Income Expense | $24,943,000 | $30,938,000 | $21,607,000 | $3,612,000 |
| Operating Expense | $205,583,000 | $204,535,000 | $215,680,000 | $182,932,000 |
| Selling And Marketing Expense | $180,578,000 | $181,366,000 | $193,042,000 | $160,576,000 |
| General And Administrative Expense | $11,686,000 | $10,032,000 | $9,228,000 | $9,931,000 |
| Other Operating Expenses | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $93,831,000 | $181,275,000 | $197,919,000 | $161,520,000 |
| Net Interest Income | $24,943,000 | $30,938,000 | $21,607,000 | $3,612,000 |
| Interest Income | $24,943,000 | $30,938,000 | $21,607,000 | $3,612,000 |
| Normalized Income | $93,831,000 | $181,275,000 | $197,919,000 | $161,520,000 |
| Net Income From Continuing And Discontinued Operation | $93,831,000 | $181,275,000 | $197,919,000 | $161,520,000 |
| Total Operating Income As Reported | $85,387,000 | $112,531,000 | $195,660,000 | $197,854,000 |
| Net Income Common Stockholders | $93,831,000 | $181,275,000 | $197,919,000 | $161,520,000 |
| Net Income | $93,831,000 | $181,275,000 | $197,919,000 | $161,520,000 |
| Net Income Including Noncontrolling Interests | $93,831,000 | $181,275,000 | $197,919,000 | $161,520,000 |
| Net Income Continuous Operations | $93,831,000 | $181,275,000 | $197,919,000 | $161,520,000 |
| Pretax Income | $110,330,000 | $143,469,000 | $217,267,000 | $201,466,000 |
| Interest Income Non Operating | $24,943,000 | $30,938,000 | $21,607,000 | $3,612,000 |
| Operating Income | $85,387,000 | $112,531,000 | $195,660,000 | $197,854,000 |
| Gross Profit | $290,970,000 | $317,066,000 | $411,340,000 | $380,786,000 |
| Per Share | ||||
| Diluted EPS | $1.43 | $2.25 | $2.30 | $1.89 |
| Basic EPS | $1.45 | $2.29 | $2.37 | $1.96 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $86,082,000 | $113,259,000 | $196,283,000 | $198,534,000 |
| Reconciled Depreciation | $695,000 | $728,000 | $623,000 | $680,000 |
| EBITDA (Bullshit earnings) | $86,082,000 | $113,259,000 | $196,283,000 | $198,534,000 |
| EBIT | $85,387,000 | $112,531,000 | $195,660,000 | $197,854,000 |
| Diluted Average Shares | $65,445,000 | $80,597,000 | $85,954,000 | $85,404,000 |
| Basic Average Shares | $64,633,000 | $79,306,000 | $83,534,000 | $82,482,000 |
| Diluted NI Availto Com Stockholders | $93,831,000 | $181,275,000 | $197,919,000 | $161,520,000 |
| Tax Provision | $16,499,000 | $-37,806,000 | $19,348,000 | $39,946,000 |
| Research And Development | $13,319,000 | $13,137,000 | $13,410,000 | $12,425,000 |
| Selling General And Administration | $192,264,000 | $191,398,000 | $202,270,000 | $170,507,000 |
| Other Gand A | $11,686,000 | $10,032,000 | $9,228,000 | $9,931,000 |
| Minority Interests | - | - | $0 | $0 |
Fetched: 2026-06-23
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $683,198,000 | $703,813,000 | $787,372,000 | $554,618,000 |
| Total Assets | $766,429,000 | $785,667,000 | $863,286,000 | $644,409,000 |
| Total Non Current Assets | $67,808,000 | $71,215,000 | $17,956,000 | $15,038,000 |
| Non Current Deferred Assets | $53,230,000 | $56,285,000 | $1,506,000 | $3,094,000 |
| Non Current Deferred Taxes Assets | $53,230,000 | $56,285,000 | $1,506,000 | $3,094,000 |
| Non Current Accounts Receivable | $3,005,000 | $3,176,000 | $3,670,000 | $3,973,000 |
| Current Assets | $698,621,000 | $714,452,000 | $845,330,000 | $629,371,000 |
| Prepaid Assets | $19,955,000 | $17,381,000 | $15,001,000 | $13,826,000 |
| Inventory | $74,050,000 | $59,548,000 | $45,095,000 | $39,897,000 |
| Receivables | $49,282,000 | $41,051,000 | $43,629,000 | $28,265,000 |
| Other Receivables | $1,829,000 | $3,293,000 | $1,201,000 | $1,224,000 |
| Taxes Receivable | $3,949,000 | $1,423,000 | $66,000 | $44,000 |
| Accounts Receivable | $43,504,000 | $36,335,000 | $42,362,000 | $26,997,000 |
| Allowance For Doubtful Accounts Receivable | $-2,371,000 | $-1,825,000 | $-1,538,000 | $-836,000 |
| Gross Accounts Receivable | $45,875,000 | $38,160,000 | $43,900,000 | $27,833,000 |
| Cash Cash Equivalents And Short Term Investments | $555,334,000 | $596,472,000 | $741,605,000 | $547,383,000 |
| Cash And Cash Equivalents | $302,543,000 | $155,329,000 | $144,411,000 | $97,540,000 |
| Debt | ||||
| Total Debt | $8,227,000 | $7,822,000 | $9,017,000 | $4,962,000 |
| Long Term Debt And Capital Lease Obligation | $5,008,000 | $5,311,000 | $6,613,000 | $3,509,000 |
| Current Debt And Capital Lease Obligation | $3,219,000 | $2,511,000 | $2,404,000 | $1,453,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $83,231,000 | $81,854,000 | $75,914,000 | $89,791,000 |
| Total Non Current Liabilities Net Minority Interest | $12,487,000 | $12,003,000 | $11,778,000 | $7,771,000 |
| Other Non Current Liabilities | $4,436,000 | $3,356,000 | $1,399,000 | $303,000 |
| Non Current Deferred Liabilities | $3,043,000 | $3,336,000 | $3,766,000 | $3,959,000 |
| Current Liabilities | $70,744,000 | $69,851,000 | $64,136,000 | $82,020,000 |
| Other Current Liabilities | $15,961,000 | $16,044,000 | $10,974,000 | $10,429,000 |
| Current Deferred Liabilities | $12,093,000 | $16,755,000 | $10,923,000 | $13,798,000 |
| Payables And Accrued Expenses | $20,383,000 | $17,094,000 | $17,319,000 | $35,483,000 |
| Payables | $18,673,000 | $14,715,000 | $15,884,000 | $35,483,000 |
| Total Tax Payable | $761,000 | $933,000 | $1,918,000 | $19,241,000 |
| Income Tax Payable | $761,000 | $933,000 | $1,918,000 | $19,241,000 |
| Accounts Payable | $17,912,000 | $13,782,000 | $13,966,000 | $16,242,000 |
| Equity | ||||
| Common Stock Equity | $683,198,000 | $703,813,000 | $787,372,000 | $554,618,000 |
| Total Equity Gross Minority Interest | $683,198,000 | $703,813,000 | $787,372,000 | $554,618,000 |
| Stockholders Equity | $683,198,000 | $703,813,000 | $787,372,000 | $554,618,000 |
| Gains Losses Not Affecting Retained Earnings | $69,000 | $-340,000 | $-1,679,000 | $-7,493,000 |
| Retained Earnings | $968,532,000 | $874,701,000 | $693,426,000 | $495,507,000 |
| Long Term Equity Investment | $700,000 | $700,000 | $700,000 | $600,000 |
| Investments In Other Ventures Under Equity Method | $700,000 | $700,000 | $700,000 | $600,000 |
| Other | ||||
| Treasury Shares Number | $24,975,003 | $18,025,003 | $1,975,003 | $1,975,003 |
| Ordinary Shares Number | $63,358,750 | $69,558,670 | $83,982,462 | $82,544,991 |
| Share Issued | $88,333,753 | $87,583,673 | $85,957,465 | $84,519,994 |
| Tangible Book Value | $683,198,000 | $703,813,000 | $787,372,000 | $554,618,000 |
| Invested Capital | $683,198,000 | $703,813,000 | $787,372,000 | $554,618,000 |
| Working Capital | $627,877,000 | $644,601,000 | $781,194,000 | $547,351,000 |
| Capital Lease Obligations | $8,227,000 | $7,822,000 | $9,017,000 | $4,962,000 |
| Total Capitalization | $683,198,000 | $703,813,000 | $787,372,000 | $554,618,000 |
| Treasury Stock | $495,269,000 | $367,825,000 | $82,440,000 | $82,440,000 |
| Additional Paid In Capital | $209,615,000 | $197,028,000 | $177,820,000 | $148,803,000 |
| Capital Stock | $251,000 | $249,000 | $245,000 | $241,000 |
| Common Stock | $251,000 | $249,000 | $245,000 | $241,000 |
| Non Current Deferred Revenue | $3,043,000 | $3,336,000 | $3,766,000 | $3,959,000 |
| Long Term Capital Lease Obligation | $5,008,000 | $5,311,000 | $6,613,000 | $3,509,000 |
| Current Deferred Revenue | $12,093,000 | $16,755,000 | $10,923,000 | $13,798,000 |
| Current Capital Lease Obligation | $3,219,000 | $2,511,000 | $2,404,000 | $1,453,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $18,157,000 | $16,725,000 | $21,040,000 | $19,439,000 |
| Current Provisions | $931,000 | $722,000 | $1,476,000 | $1,418,000 |
| Current Accrued Expenses | $1,710,000 | $2,379,000 | $1,435,000 | - |
| Investments And Advances | $700,000 | $700,000 | $700,000 | $600,000 |
| Net PPE | $10,873,000 | $11,054,000 | $12,080,000 | $7,371,000 |
| Accumulated Depreciation | $-4,880,000 | $-4,185,000 | $-3,457,000 | $-2,834,000 |
| Gross PPE | $15,753,000 | $15,239,000 | $15,537,000 | $10,205,000 |
| Leases | $1,422,000 | $1,333,000 | $1,243,000 | $829,000 |
| Other Properties | $12,079,000 | $11,752,000 | $12,290,000 | $7,623,000 |
| Machinery Furniture Equipment | $2,252,000 | $2,154,000 | $2,004,000 | $1,753,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $46,863,000 | $44,094,000 | $33,015,000 | $26,211,000 |
| Raw Materials | $27,187,000 | $15,454,000 | $12,080,000 | $13,686,000 |
| Other Short Term Investments | $252,791,000 | $441,143,000 | $597,194,000 | $449,843,000 |
| Minority Interest | - | - | - | $0 |
| Other Investments | - | - | - | - |
Fetched: 2026-06-23
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $84,285,000 | $131,995,000 | $176,121,000 | $180,003,000 |
| Operating Activities | ||||
| Operating Cash Flow | $85,257,000 | $132,664,000 | $176,826,000 | $181,578,000 |
| Cash Flow From Continuing Operating Activities | $85,257,000 | $132,664,000 | $176,826,000 | $181,578,000 |
| Operating Gains Losses | $15,000 | $167,000 | - | $71,000 |
| Investing Activities | ||||
| Capital Expenditure | $-972,000 | $-669,000 | $-705,000 | $-1,575,000 |
| Investing Cash Flow | $186,032,000 | $162,206,000 | $-136,064,000 | $-109,474,000 |
| Cash Flow From Continuing Investing Activities | $186,032,000 | $162,206,000 | $-136,064,000 | $-109,474,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-127,444,000 | $-285,385,000 | $0 | $-42,637,000 |
| Financing Cash Flow | $-126,059,000 | $-282,771,000 | $5,504,000 | $-41,085,000 |
| Cash Flow From Continuing Financing Activities | $-126,059,000 | $-282,771,000 | $5,504,000 | $-41,085,000 |
| Net Common Stock Issuance | $-127,444,000 | $-285,385,000 | $0 | $-42,637,000 |
| Issuance Of Capital Stock | - | - | - | - |
| Common Stock Issuance | - | - | - | - |
| Other | ||||
| Income Tax Paid Supplemental Data | $14,867,000 | $17,691,000 | $31,614,000 | $25,843,000 |
| End Cash Position | $302,543,000 | $155,329,000 | $144,411,000 | $97,540,000 |
| Beginning Cash Position | $155,329,000 | $144,411,000 | $97,540,000 | $68,136,000 |
| Effect Of Exchange Rate Changes | $1,984,000 | $-1,181,000 | $605,000 | $-1,615,000 |
| Changes In Cash | $145,230,000 | $12,099,000 | $46,266,000 | $31,019,000 |
| Proceeds From Stock Option Exercised | $1,385,000 | $2,614,000 | $5,504,000 | $1,552,000 |
| Common Stock Payments | $-127,444,000 | $-285,385,000 | $0 | $-42,637,000 |
| Net Investment Purchase And Sale | $187,004,000 | $162,875,000 | $-135,359,000 | $-107,899,000 |
| Sale Of Investment | $500,518,000 | $667,283,000 | $343,319,000 | $154,482,000 |
| Purchase Of Investment | $-313,514,000 | $-504,408,000 | $-478,678,000 | $-262,381,000 |
| Net PPE Purchase And Sale | $-972,000 | $-669,000 | $-705,000 | $-1,575,000 |
| Purchase Of PPE | $-972,000 | $-669,000 | $-705,000 | $-1,575,000 |
| Change In Working Capital | $-24,295,000 | $-7,067,000 | $-41,438,000 | $-4,468,000 |
| Change In Other Working Capital | $-4,955,000 | $5,402,000 | $-3,068,000 | $1,201,000 |
| Change In Other Current Liabilities | $2,163,000 | $1,917,000 | $-12,588,000 | $17,941,000 |
| Change In Payables And Accrued Expense | $4,129,000 | $-184,000 | $-2,276,000 | $7,463,000 |
| Change In Payable | $4,129,000 | $-184,000 | $-2,276,000 | $7,463,000 |
| Change In Account Payable | $4,129,000 | $-184,000 | $-2,276,000 | $7,463,000 |
| Change In Inventory | $-14,502,000 | $-14,453,000 | $-5,198,000 | $-18,871,000 |
| Change In Receivables | $-11,130,000 | $251,000 | $-18,308,000 | $-12,202,000 |
| Changes In Account Receivables | $-7,452,000 | $5,949,000 | $-16,084,000 | $-10,415,000 |
| Other Non Cash Items | $498,000 | $-4,401,000 | $-4,714,000 | $-1,210,000 |
| Stock Based Compensation | $11,131,000 | $16,569,000 | $23,600,000 | $24,452,000 |
| Provisionand Write Offof Assets | $454,000 | $572,000 | $1,020,000 | $449,000 |
| Deferred Tax | $2,928,000 | $-55,179,000 | $-184,000 | $84,000 |
| Deferred Income Tax | $2,928,000 | $-55,179,000 | $-184,000 | $84,000 |
| Depreciation Amortization Depletion | $695,000 | $728,000 | $623,000 | $680,000 |
| Depreciation And Amortization | $695,000 | $728,000 | $623,000 | $680,000 |
| Depreciation | $695,000 | $728,000 | $623,000 | $680,000 |
| Gain Loss On Investment Securities | $15,000 | $167,000 | - | $71,000 |
| Net Income From Continuing Operations | $93,831,000 | $181,275,000 | $197,919,000 | $161,520,000 |
| Change In Accrued Expense | - | - | - | - |
Fetched: 2026-06-23